Protocol Ledger

NCT07218523 · Phase III · RECRUITING

A Study to Investigate Bowel Cleansing With PLENVU® Compared to Sodium Picosulfate in Participants Aged 1 to < 18 Years of Age in Preparation for Colonoscopy

Interventional Phase III clinical trial protocol NCT07218523 sponsored by Norgine in Rare Genetic, Women's Health, and Other, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2025-12-29 Enrollment: 212 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT07218523
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)212 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)1 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT07218523
Protocol FieldVerified Registry Value
NCT IdentifierNCT07218523
Consolidated Lead SponsorNorgine
Therapeutic Condition CohortRare Genetic, Women's Health, and Other
Clinical Trial PhasePhase III
Overall Recruitment StatusRECRUITING
Registered Enrollment212 participants (ESTIMATED)
Registered Start Date2025-12-29
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Listed on NCT07218523
Hospital Research SiteLocationSite Profile
Charité Universitätsmedizin BerlinBerlin, GermanyOpen Hospital Dossier ->

Search related sites and sponsors in the Interactive Directory, explore Rare Genetic, Women's Health, and Other Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI